Uma Devi Ranganathan

Department of Immunology, National Institute for Research in Tuberculosis

Affiliated withNational Institute for Research in Tuberculosis Academy of Scientific and Innovative Research (AcSIR)

Research Area

Biography

Uma Devi Ranganathan has not added Biography.
If you are Uma Devi Ranganathan and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 3	Year
Publication title	2025
Publication title	2025
Publication title Cited by 2	2025

Other Publications

Article	Year
Homology modeling, substrate docking, and molecular simulation studies of mycobacteriophage Che12 lysin A. Journal of molecular modeling\| PubMed ID: 27411553	2016
Monocyte Subsets: Phenotypes and Function in Tuberculosis Infection. Frontiers in immunology\| PubMed ID: 30105020	2018
Current trends in tuberculosis vaccine. Medical journal, Armed Forces India\| PubMed ID: 30705473	2019
Diverse Clinical Isolates of Mycobacterium tuberculosis Develop Macrophage-Induced Rifampin Tolerance. The Journal of infectious diseases\| PubMed ID: 30753612	2019
Genome Sequencing of Polydrug-, Multidrug-, and Extensively Drug-Resistant Mycobacterium tuberculosis Strains from South India. Microbiology resource announcements\| PubMed ID: 30938706	2019
In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates. Journal of global antimicrobial resistance\| PubMed ID: 31226332	2019
Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India. Scientific reports\| PubMed ID: 31311987	2019
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020. The Indian journal of medical research\| PubMed ID: 32952144	2020
Vitamin D - A host directed autophagy mediated therapy for tuberculosis. Molecular immunology\| PubMed ID: 33039674	2020
Spoligotype Diversity of over Two Decades from Tiruvallur, South India. International journal of microbiology\| PubMed ID: 33110429	2020
The recent trend in mycobacterial strain diversity among extra pulmonary lymph node tuberculosis and their association with drug resistance and the host immunological response in South India... BMC infectious diseases\| PubMed ID: 33243148	2020
Whole genome sequencing based differentiation between re-infection and relapse in Indian patients with tuberculosis recurrence, with and without HIV co-infection. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases\| PubMed ID: 33741489	2021
Autophagy Induction as a Host-Directed Therapeutic Strategy against Infection. Medicina (Kaunas, Lithuania)\| PubMed ID: 34070995	2021
Monocyte and Macrophage miRNA: Potent Biomarker and Target for Host-Directed Therapy for Tuberculosis. Frontiers in immunology\| PubMed ID: 34248945	2021
Whole-Genome Sequencing to Identify Missed Rifampicin and Isoniazid Resistance Among Tuberculosis Isolates-Chennai, India, 2013-2016. Frontiers in microbiology\| PubMed ID: 34880835	2021
Whole Genome Sequencing Assessing Impact of Diabetes Mellitus on Tuberculosis Mutations and Type of Recurrence in India. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 34984435	2022
Differential Frequencies of Intermediate Monocyte Subsets Among Individuals Infected With Drug-Sensitive or Drug-Resistant . Frontiers in immunology\| PubMed ID: 35911760	2022
Unique cellular immune signatures of multisystem inflammatory syndrome in children. PLoS pathogens\| PubMed ID: 36322537	2022
Role of matrix metalloproteinases in multi-system inflammatory syndrome and acute COVID-19 in children. Frontiers in medicine\| PubMed ID: 36544496	2022
Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severity. Scientific reports\| PubMed ID: 36646786	2023
Plasma chemokines CXCL10 and CXCL9 as potential diagnostic markers of drug-sensitive and drug-resistant tuberculosis. Scientific reports\| PubMed ID: 37149713	2023
Downregulation of monocyte miRNAs: implications for immune dysfunction and disease severity in drug-resistant tuberculosis. Frontiers in immunology\| PubMed ID: 37457712	2023
Multisystem inflammatory syndrome in children characterized by enhanced antigen-specific T-cell expression of cytokines and its reversal following recovery. Frontiers in pediatrics\| PubMed ID: 38116577	2023
Sex-specific differences in systemic immune responses in MIS-C children. Scientific reports\| PubMed ID: 38243064	2024
A systematic review and meta-analysis of circulating serum and plasma microRNAs in TB diagnosis. BMC infectious diseases\| PubMed ID: 38622570	2024
Association of CYP27B1 gene polymorphisms with pulmonary tuberculosis and vitamin D levels. Gene\| PubMed ID: 38876405	2024
Elucidating the Immune Response to SARS-CoV-2: Natural Infection versus Covaxin/Covishield Vaccination in a South Indian Population. Viruses\| PubMed ID: 39205152	2024
Phenotypic and genotypic characterization of pyrazinamide resistance-India, 2018-2020. Frontiers in microbiology\| PubMed ID: 39845030	2024
The importance of inflammatory biomarkers in detecting and managing latent tuberculosis infection. Frontiers in immunology\| PubMed ID: 39981231	2025
Association of CYP27B1 promoter gene variants of vitamin D pathway with pulmonary tuberculosis and vitamin D levels. Steroids\| PubMed ID: 40639560	2025